Details of the Drug
General Information of Drug (ID: DMD1258)
| Drug Name | 
                     10-Propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        10Pr-DBOA-11one; 10-Propyl-dibenz(b,f)(1,4)oxazepin-11-(10H)-one; 135810-41-2; 5-propylbenzo[b][1,4]benzoxazepin-6-one; 10-Propyl-dibenz[b,f][1,4]oxazepin-11-(10H)-one; Dibenzoxazepinone 1; AC1L9R9M; CHEMBL56451; SCHEMBL9004262; BDBM1973; DTXSID50159532; OGPOBJPKGVLINB-UHFFFAOYSA-N; 10-propyl-10H-dibenz[b,f][1.4]oxazepin-11-one; 10-Propyldibenz[b,f][1,4]oxazepin-11(10H)-one
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 253.29 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


